Send feedback

CRYBB3 p.Ala2=

c.6G>A · rs144393956 · VCV703368

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 4 submitters
gnomAD v4.1
Rare
rare (popmax 0.437%, afr)
Conditions
1
cataract 22 multiple types

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -11GERP -2.7
Overall
CADD0.251PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.437% African / African-American · 328/74,996 alleles
Filtering AF 0.398% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.383%
Overall 0.0774% 1,249/1,613,314 alleles · rare exomes 989/1,461,074 · genomes 260/152,240 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 1.71% 59
African / African-Americangrpmax 0.437% 229
Remaining individualsnot grpmax-eligible 0.16% 625
Middle Eastern 0.0828% 1,208
Admixed American 0.0817% 1,224
European (non-Finnish) 0.0221% 4,519
South Asian 0.0011% 91,062

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CRYBB3
Protein
p.Ala2=
Coding
c.6G>A
MANE Select
NM_004076
dbSNP
rs144393956
Type
single nucleotide variant
Location
chr22:25201402 (GRCh38)
Gene constraint
LOEUF 1.588 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 87.52 · 1 PDB
Residue 2
a modified residue (n-acetylalanine; in beta-crystallin b3, n-terminally processed); the 'n-terminal arm' region
Full CRYBB3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

cataract 22 multiple types — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Early onset non-syndromic cataract (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive, X-linked recessive
Onset
Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/crybb3-p-ala2 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown